Korean J Med.  2010 Feb;78(2):261-265.

A case of hypophosphatemic osteomalacia associated with low-dose adefovir dipivoxil treatment

Affiliations
  • 1Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea.
  • 2Department of Nephrology, Hanyang University College of Medicine, Seoul, Korea.
  • 3Department of Gastroenterology, Hanyang University College of Medicine, Seoul, Korea.
  • 4Department of Endocrinology, Hanyang University College of Medicine, Seoul, Korea.
  • 5Department of Hospital for Rheumatic Diseases, Hanyang University College of Medicine, Seoul, Korea. junjb@hanyang.ac.kr

Abstract

Adefovir dipivoxil (ADV) effectively inhibits lamivudine-resistant hepatitis B virus replication. Hypophosphatemia and elevated serum creatinine are ADV-related nephrotoxicity caused by high-dose ADV. Hypophosphatemic osteomalacia is very rare and is induced by low-dose ADV. A 61-year-old man suffering from chronic hepatitis B manifested with generalized myalgia and bone pain, especially in both ankles and knees. He had been administered ADV for 56 months, since lamivudine-resistant HBV was detected. He developed severe hypophosphatemia and elevated serum alkaline phosphatase levels with a high bone fraction. Bone densitometry and a whole-body bone scan revealed osteoporosis and multiple hot uptake lesions. Blood chemistry and clinical symptoms improved after discontinuing the ADV.

Keyword

Adefovir dipivoxil; Nephrotoxicity; Hypophosphatemia; Osteomalacia

MeSH Terms

Adenine
Alkaline Phosphatase
Animals
Ankle
Creatinine
Densitometry
Hepatitis B virus
Hepatitis B, Chronic
Humans
Hypophosphatemia
Knee
Middle Aged
Organophosphonates
Osteomalacia
Osteoporosis
Stress, Psychological
Adenine
Alkaline Phosphatase
Creatinine
Organophosphonates
Full Text Links
  • KJM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr